Ovarian Cancer Patient Questionnaire on Genetic Testing
Questionnaire for Ovarian Cancer Patients Regarding Acceptance and Willingness to Undergo Genetic Testing
1 other identifier
observational
237
1 country
1
Brief Summary
The objective of this study is to evaluate the willingness of patients with ovarian cancer to undergo genetic testing, given the cost, their understanding and acceptance of genetic testing and the possibility of targeted therapy.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jun 2007
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2007
CompletedFirst Submitted
Initial submission to the registry
June 13, 2007
CompletedFirst Posted
Study publicly available on registry
June 15, 2007
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2008
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2008
CompletedAugust 1, 2012
July 1, 2012
1.3 years
June 13, 2007
July 31, 2012
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Participants' Response to Survey Questions (Yes/No)
15-20 minutes to complete survey
Study Arms (1)
Patients with ovarian cancer
Interventions
A questionnaire will be completed.
Eligibility Criteria
Study participants with a diagnosis of ovarian cancer.
You may qualify if:
- Patients must have the diagnosis of ovarian cancer.
- Patients must be at least 18 years of age at the time of enrollment.
- Patients must be able to read and write in the English language.
You may not qualify if:
- Patients that are unable to speak or write in the English language. Currently, the investigators' resources in genetic counseling are limited. In the future, they plan to expand the questionnaire and study to include additional languages.
- Patients having previously undergone BRCA genetic testing.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
U.T.M.D. Anderson Cancer Center
Houston, Texas, 77030, United States
Related Publications (1)
Lacour RA, Daniels MS, Westin SN, Meyer LA, Burke CC, Burns KA, Kurian S, Webb NF, Pustilnik TB, Lu KH. What women with ovarian cancer think and know about genetic testing. Gynecol Oncol. 2008 Oct;111(1):132-6. doi: 10.1016/j.ygyno.2008.06.016. Epub 2008 Aug 6.
PMID: 18684498BACKGROUND
Related Links
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Karen H. Lu, MD
M.D. Anderson Cancer Center
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 13, 2007
First Posted
June 15, 2007
Study Start
June 1, 2007
Primary Completion
October 1, 2008
Study Completion
October 1, 2008
Last Updated
August 1, 2012
Record last verified: 2012-07